North America In Vitro Diagnostics Market Growth & Trends
The North America in vitro diagnostics market size is expected to reach USD 39.67 billion by 2030 and is expected to decline at 2.89% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. On the other hand, the market is also expected to cater to various growth opportunities in key segments. For example, the development of automated in vitro diagnostic solutions for hospitals and laboratories to provide accurate, efficient, and error-free diagnosis is anticipated to drive market growth in the coming years. In addition, rising efforts to develop POC solutions and the surge in adoption of POC tests across different medical diagnostic applications, including infectious diseases, pregnancy, cancer, and others, are fueling the market growth.
The market growth is likely to be fueled by rising efforts from leading participants to develop fast and accurate products that allow easy-to-use, advanced, and flexible testing options. For instance, in August 2022, DxGen Corp. and Precision Diabetes, Inc. announced an agreement to develop and launch a fully automatic POC analyzer in the U.S. market to measure a complete profile of diabetes tests. The analyzer is capable to test C-reactive protein, urine analysis, A1C levels, and other diabetes confirmatory tests at POC facilities.
North America In Vitro Diagnostics Market Report Scope
Report Attribute | Details |
Market size value in 2023 | USD 48.19 billion |
Revenue forecast in 2030 | USD 39.67 billion |
Growth rate | CAGR of -2.89% from 2023 to 2030 |
Base year for estimation | 2022 |
Historical data | 2018 - 2021 |
Forecast period | 2023 - 2030 |
Furthermore, in November 2021, Lumos Diagnostics, a key player in POC diagnostics, announced that its Lumos CoviDx SARS-CoV-2 Rapid Antigen Test received an interim order authorization from Health Canada. This test offers easy-to-interpret outcomes in just 15-20 minutes in serial testing of asymptomatic patients. The easy availability of point-of-care tests in home care settings, community pharmacies, retail health clinics, urgent care centers, intensive care units, and operating rooms is fueling the adoption of POC IVD products across the region.
The North America in vitro diagnostics industry is gaining traction as diagnostic laboratories frequently employ fully automated tools. Moreover, automated devices are highly scalable, meet a high level of performance expectations, eliminate batch testing, and provide quick results to medical professionals. Leading participants are continuously working on building automated devices because of these benefits. For instance, in May 2022, BD launched a new, fully automated high-throughput infectious disease molecular diagnostics platform in the U.S. market.
Furthermore, the increasing incidence of target diseases, favorable government initiatives, and the flourishing healthcare sector in the region are anticipated to offer lucrative growth opportunities.
For instance, in November 2022, Hologic, Inc. was awarded a USD 19 million contract from BARDA to support its research and development activities. In addition, in January 2022, Aline, Inc. & Nectar Product Development announced a strategic partnership to improve POC in vitro diagnostic products.
Request a free sample copy or view report summary: North America In Vitro Diagnostics Market Report
North America In Vitro Diagnostics Market Report Highlights
- The reagents segment held the largest market share in 2022 owing to extensive R&D initiatives being undertaken by major market players for the development of novel test kits
- The molecular diagnostics segment accounted for the largest market share in 2022, thanks to rapid evolution in technology, increasing burden of target diseases, and surge in product launches by leading participants
- Based on application, the infectious disease segment dominated the market in terms of revenue share in 2022. On the other hand, the oncology segment is expected to be the fastest-growing segment over the forecast period
- The hospitals segment was the largest end-user in 2022, owing to the rising demand for affordable services, the surging trend for personalized treatments, and the presence of favorable reimbursement policies
- Canada is expected to exhibit the fastest growth over the forecast period in the region due to the increasing geriatric population, and large patient pool with a high prevalence of chronic diseases
Access Press Release@ https://www.grandviewresearch.com/press-release/north-america-in-vitro-diagnostics-market-analysis
North America In Vitro Diagnostics Market Segmentation
Grand View Research has segmented the North America in vitro diagnostics market based on product, technology, application, end-use, test location, and country:
North America In Vitro Diagnostics Product Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)
- Instruments
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Reagents
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- End-use
- End-use
- End-use
North America In Vitro Diagnostics Technology Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)
- Immunoassay
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Hematology
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Clinical Chemistry
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Molecular Diagnostics
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Coagulation
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Microbiology
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Others
- Product
- Instruments
- Reagents
- Services
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Product
- Product
- Product
- Product
- Product
- Product
- Product
North America In Vitro Diagnostics Application Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)
- Infectious Disease
- Disease
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium Difficile
- Vancomycin-resistant Enterococci (VRE)
- Carbapenem-resistant Bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis and Drug-resistant TBA
- Meningitis
- Gastrointestinal Panel Testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Other Infectious Diseases
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Diabetes
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Oncology
- Disease
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Kidney Cancer
- Liver Cancer
- Blood Cancer
- Lung Cancer
- Other Cancer
- End-Use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Cardiology
- Disease
- Coronary Heart Disease
- Stroke
- Peripheral Arterial Disease
- Aortic Disease
- Others
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Nephrology
- Disease
- UTI
- Kidney Disease
- Diabetes
- Others
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Autoimmune Diseases
- Disease
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Osteoporosis
- Celiac Disease
- Fibromyalgia
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Drug Testing
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- Others
- End-use
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
- End-use
- End-use
- Disease
- Disease
- Disease
- Disease
- End-use
- Disease
North America In Vitro Diagnostics End-use Outlook (Volume, Number of Tests and Instruments; Revenue, USD Million, 2018 - 2030)
- Hospitals
- Laboratories
- Home Care
- Clinic/Others
- Physician Office
- Pharmacy & Retail Clinics
- Non-practice Clinics
- Urgent Care Clinics
- Others
North America In Vitro Diagnostics Test Location Outlook (Revenue, USD Million, 2018 - 2030)
- Point-of-Care
- Others
North America In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- US.
- Canada
List of Key Players in the North America In Vitro Diagnostics Market
- Abbott
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- BD
- Siemens Healthcare GmbH
- QIAGEN
- Quidel Corporation
- Hoffmann-La Roche Ltd
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- Quest Diagnostics
- Agilent Technologies, Inc.
- Danaher
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment